Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants - PubMed (original) (raw)
Review
Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants
Ocky K Radjasa et al. Bioorg Med Chem. 2011.
Abstract
Coral reefs are among the most productive marine ecosystems and are the source of a large group of structurally unique biosynthetic products. Annual reviews of marine natural products continue to illustrate that the most prolific source of bioactive compounds consist of coral reef invertebrates-sponges, ascidians, mollusks, and bryozoans. This account examines recent milestone developments pertaining to compounds from invertebrates designated as therapeutic leads for biomedical discovery. The focus is on the secondary metabolites, their inspirational structural scaffolds and the possible role of micro-organism associants in their biosynthesis. Also important are the increasing concerns regarding the collection of reef invertebrates for the discovery process. The case examples considered here will be useful to insure that future research to unearth bioactive invertebrate-derived compounds will be carried out in a sustainable and environmentally conscious fashion. Our account begins with some observations pertaining to the natural history of these organisms. Many still believe that a serious obstacle to the ultimate development of a marine natural product isolated from coral reef invertebrates is the problem of compound supply. Recent achievements through total synthesis can now be drawn on to forcefully cast this myth aside. The tools of semisynthesis of complex natural products or insights from SAR efforts to simplify an active pharmacophore are at hand and demand discussion. Equally exciting is the prospect that invertebrate-associated micro-organisms may represent the next frontier to accelerate the development of high priority therapeutic candidates. Currently in the United States there are two FDA approved marine-derived therapeutic drugs and two others that are often cited as being marine-inspired. This record will be examined first followed by an analysis of a dozen of our favorite examples of coral reef invertebrate natural products having therapeutic potential. The record of using complex scaffolds of marine invertebrate products as the starting point for development will be reviewed by considering eight case examples. The potential promise of developing invertebrate-derived micro-organisms as the starting point for further exploration of therapeutically relevant structures is considered. Also significant is the circumstance that there are some 14 sponge-derived compounds that are available to facilitate fundamental biological investigations.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
Figure 1
Natural history of coral reef invertebrates with potential as a source of significant metabolites.
Figure 2
Marine sponge associated micro-organisms as potential candidates for producing secondary metabolites. (Adapted from Ref. 76)
Figure 3
Histogram of peer-review publications on the latrunculin class isolated from marine sponges covering 1983–2010.
Scheme 1
Semisynthetic route beginning with cyanosafracin B, obtained from fermentation to ecteinascidin 743 (1).
Scheme 1
Semisynthetic route beginning with cyanosafracin B, obtained from fermentation to ecteinascidin 743 (1).
Similar articles
- Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications.
Romano G, Almeida M, Varela Coelho A, Cutignano A, Gonçalves LG, Hansen E, Khnykin D, Mass T, Ramšak A, Rocha MS, Silva TH, Sugni M, Ballarin L, Genevière AM. Romano G, et al. Mar Drugs. 2022 Mar 22;20(4):219. doi: 10.3390/md20040219. Mar Drugs. 2022. PMID: 35447892 Free PMC article. Review. - Drug discovery from marine microbes.
Gerwick WH, Fenner AM. Gerwick WH, et al. Microb Ecol. 2013 May;65(4):800-6. doi: 10.1007/s00248-012-0169-9. Epub 2012 Dec 30. Microb Ecol. 2013. PMID: 23274881 Free PMC article. Review. - Marine Invertebrate Natural Products that Target Microtubules.
Miller JH, Field JJ, Kanakkanthara A, Owen JG, Singh AJ, Northcote PT. Miller JH, et al. J Nat Prod. 2018 Mar 23;81(3):691-702. doi: 10.1021/acs.jnatprod.7b00964. Epub 2018 Feb 12. J Nat Prod. 2018. PMID: 29431439 Review. - Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates.
McCauley EP, Piña IC, Thompson AD, Bashir K, Weinberg M, Kurz SL, Crews P. McCauley EP, et al. J Antibiot (Tokyo). 2020 Aug;73(8):504-525. doi: 10.1038/s41429-020-0330-5. Epub 2020 Jun 8. J Antibiot (Tokyo). 2020. PMID: 32507851 Free PMC article. Review. - Molecular architecture and biomedical leads of terpenes from red sea marine invertebrates.
Hegazy ME, Mohamed TA, Alhammady MA, Shaheen AM, Reda EH, Elshamy AI, Aziz M, Paré PW. Hegazy ME, et al. Mar Drugs. 2015 May 20;13(5):3154-81. doi: 10.3390/md13053154. Mar Drugs. 2015. PMID: 26006713 Free PMC article. Review.
Cited by
- Testacosides A-D, glycoglycerolipids produced by Microbacterium testaceum isolated from Tedania brasiliensis.
Quintana-Bulla JI, Tonon LAC, Michaliski LF, Hajdu E, Ferreira AG, Berlinck RGS. Quintana-Bulla JI, et al. Appl Microbiol Biotechnol. 2024 Dec;108(1):112. doi: 10.1007/s00253-023-12870-0. Epub 2024 Jan 12. Appl Microbiol Biotechnol. 2024. PMID: 38217254 Free PMC article. - Naturally Occurring Organohalogen Compounds-A Comprehensive Review.
Gribble GW. Gribble GW. Prog Chem Org Nat Prod. 2023;121:1-546. doi: 10.1007/978-3-031-26629-4_1. Prog Chem Org Nat Prod. 2023. PMID: 37488466 Review. - Marine Microbial-Derived Resource Exploration: Uncovering the Hidden Potential of Marine Carotenoids.
Steven R, Humaira Z, Natanael Y, Dwivany FM, Trinugroho JP, Dwijayanti A, Kristianti T, Tallei TE, Emran TB, Jeon H, Alhumaydhi FA, Radjasa OK, Kim B. Steven R, et al. Mar Drugs. 2022 May 26;20(6):352. doi: 10.3390/md20060352. Mar Drugs. 2022. PMID: 35736155 Free PMC article. Review. - _Dactylospongia elegans_-A Promising Drug Source: Metabolites, Bioactivities, Biosynthesis, Synthesis, and Structural-Activity Relationship.
Ibrahim SRM, Fadil SA, Fadil HA, Hareeri RH, Alolayan SO, Abdallah HM, Mohamed GA. Ibrahim SRM, et al. Mar Drugs. 2022 Mar 23;20(4):221. doi: 10.3390/md20040221. Mar Drugs. 2022. PMID: 35447894 Free PMC article. Review. - Enigmazole C: A Cytotoxic Macrocyclic Lactone and Its Ring-Opened Derivatives from a New Species of Homophymia Sponge.
Tarazona G, Fernández R, Pérez M, Millán RE, Jiménez C, Rodríguez J, Cuevas C. Tarazona G, et al. J Nat Prod. 2022 Apr 22;85(4):1059-1066. doi: 10.1021/acs.jnatprod.1c01179. Epub 2022 Mar 2. J Nat Prod. 2022. PMID: 35234467 Free PMC article. Review.
References
- Ann. N.Y. Acad. Sci. 1960;90:617. - PubMed
- Ruggieri GD. Science. 1976;194:491. - PubMed
- Rinehart K, Gloer JB, Cook JC. J. Am. Chem. Soc. 1981;103:1857.
- Newman DJ, Cragg GM. J. Nat. Prod. 2004;67:1216. - PubMed
- National Research Council. Marine Biotechnology in the Twenty-first Century: Problems, Promise, and Products. Washington, DC: National Academy Press; 2002. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous